December 12, 2018
Ribomic, a nucleic acid drug discovery upstart originated from the University of Tokyo, said on December 10 that it has entered into a material transfer agreement with the University of Michigan, a member of the Pritzker Neuropsychiatric Disorders Research Consortium,...read more